Digiceuticals Market Trends

  • Report ID: 5540
  • Published Date: May 07, 2024
  • Report Format: PDF, PPT

Digiceuticals Market Trends

Growth Drivers

  • Increasing adoption of wearable technology - Wearable technology have revolutionized the healthcare industry by providing real-time health monitoring and tracking capabilities. These devices, such as smart watches and fitness trackers, enable individuals to monitor their vital signs, activity levels, and sleep patterns, empowering them to take control of their health and well-being.
    According to a study over 22% of Americans make use of smart watches or wearable fitness trackers. In the year 2019 consumers in the United States purchased, over 52 million units of fitness trackers, including both smart watches and fitness bands.
  • Rise in use of mobile health apps - Mobile health apps have become increasingly popular as a tool for managing health and wellness. As of 2019 over 2.6 billion individuals across the globe possessed smartphones, with a staggering 52% of them having mobile health applications installed on their devices. These apps allow users to track their exercise, monitor their diet, and receive personalized health recommendations. They also provide access to a wealth of health information and resources, making it easier for individuals to make informed decisions about their health.
    As people are increasingly relying on their mobile devices for health information, there has been a rise in the use of mobile health apps. This has enabled the development of digital therapeutics, which are apps that are designed to help people with chronic illnesses manage their symptoms.
  • The rising popularity of remote patient monitoring (RPM) systems - Remote patient monitoring systems enables healthcare providers to remotely monitor and manage patients' health conditions. A thorough study revealed that patient involvement increased when using remote patient monitoring (RPM). The study involved than 7,000 patients from 42 different states and the results indicated that patient engagement, with digital RPM tools reached an impressive rate of 82%.
    These systems use connected devices to collect and transmit patient data, allowing healthcare professionals to track vital signs, detect early warning signs, and intervene when necessary. With the rising cost of healthcare, mobile remote patient monitoring systems are becoming increasingly popular as they allow for remote monitoring of patients, reducing the need for in-person visits and allowing for more cost-effective care. This rise in the use of mobile remote patient monitoring systems is driving the growth of the digiceuticals market.

Challenges

  • Regulatory challenges - The digiceuticals industry is heavily regulated, with strict guidelines governing the development and marketing of digital health products. This can create significant barriers to entry for new companies and limit innovation in the industry.
  • The lack of standardization and interoperability between different digital platforms
  • Data security and privacy concerns are also set to impeding the digiceuticals market growth in the forecast period.

Digiceuticals Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

~33%

Base Year Market Size (2023)

~ USD 5 Billion

Forecast Year Market Size (2036)

~ USD 115 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5540
  • Published Date: May 07, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

: The growth of the digiceuticals market is being driven by several factors, such as the rising popularity of digital health technologies, the increasing need for personalized healthcare, the increasing prevalence of chronic diseases, and the rising cost of traditional healthcare.

The market size of digiceuticals is anticipated to attain a CAGR of 33% over the forecast period, i.e., 2024-2036.

The major players in the market are Pear therapeutics Inc., Akili Interactive Labs, Inc., Chrono Therapeutics Inc., Click Therapeutics, Omada Health, Canary Health, Inc., Glooko, Inc., Propeller helath, Welldoc, Voluntis, and others.

The smartphone segment is anticipated to garner the largest market size of 38% by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share of 31% by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying